Publications by authors named "Alexie Mayor"

Claim this Profile
I
Inhaled IgG1 antibodies: The buffering system is an important driver of stability during mesh-nebulization.
Alexie Mayor, Béatrice Thibert, Sylvain Huille, Fethi Bensaid, Renaud Respaud

Eur J Pharm Biopharm· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled antibodies: formulations require specific development to overcome instability due to nebulization.
Alexie Mayor, Béatrice Thibert, Sylvain Huille, Renaud Respaud, Héloïse Audat

Drug Deliv Transl Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Antibodies for the Treatment of Respiratory Tract Infections-Current Overview and Perspectives.
Alexie Mayor, Adélaïde Chesnay, Guillaume Desoubeaux, David Ternant, Nathalie Heuzé-Vourc'h

Vaccines (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!
Thomas Sécher, Alexie Mayor, Nathalie Heuzé-Vourc'h

Front Immunol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designing inhaled protein therapeutics for topical lung delivery: what are the next steps?
Elsa Bodier-Montagutelli, Alexie Mayor, Laurent Vecellio, Renaud Respaud, Nathalie Heuzé-Vourc'h

Expert Opin Drug Deliv· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis